<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03164798</url>
  </required_header>
  <id_info>
    <org_study_id>2016-08-059</org_study_id>
    <nct_id>NCT03164798</nct_id>
  </id_info>
  <brief_title>Serum BDNF Role as a Biomarker for Stroke Rehabilitation</brief_title>
  <acronym>BDNF</acronym>
  <official_title>Serum BDNF Role as a Biomarker for Stroke Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to develop the quantitative biomarker to establish the individualized
      strategy in stroke rehabilitation. Brain-derived neurotrophic factor (BDNF) acts on certain
      neurons of the central nervous system (CNS) helping to support the survival of existing
      neurons, and encourage the growth and differentiation of new neurons and synapses. BDNF in
      CNS can be assessed by analysing serum BDNF. The final objective of this study is to
      demonstrate a role of biomarker of BDNF in stroke rehabilitation to establish the
      individualized strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Serum BDNF, proBDNF and MMP-9 in all participants will be measured before and after the
      comprehensive inpatient rehabilitation during subacute stroke phase. At 3 months after stroke
      onset, serum BDNF, proBDNF and MMP-9 will also be measured.

      In addition, motor impairment with Fugl-Meyer assessement will be assessed at same time
      points with serum analysis.

      We will compare potential serum biomarkers with motor impairment in stroke patients
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum BDNF</measure>
    <time_frame>At 2 weeks after the comprehensive inpatient rehabilitation</time_frame>
    <description>serum BDNF level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum proBDNF</measure>
    <time_frame>At 2 weeks after the comprehensive inpatient rehabilitation</time_frame>
    <description>Serum proBDNF level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMP-9</measure>
    <time_frame>At 2 weeks after the comprehensive inpatient rehabilitation</time_frame>
    <description>MMP-9 level</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stroke</condition>
  <condition>Biomarker</condition>
  <condition>Rehabilitation</condition>
  <condition>BDNF</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional inpatient rehabilitation</intervention_name>
    <description>comprehensive inpatient rehabilitation for 2 weeks</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      BDNF Val66Met polymorphism
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subacute stroke patients who were received the comprehensive inpatients rehabilitation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unilateral stroke patients

          -  admission to the rehabilitation department before 1 month after stroke onset

          -  mild to severe motor impairment at time of transferring to the rehabilitation
             department

        Exclusion Criteria:

          -  Progressive or unstable stroke

          -  Pre-existing and active major neurological disease

          -  Pre-existing and active major psychiatric disease

          -  Advanced liver, kidney, cardiac, or pulmonary disease

          -  A terminal medical diagnosis consistent with survival &lt; 1 year)

          -  Pregnant or lactating woman
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won Hyuk Chang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Won Hyuk Chang, MD, PhD</last_name>
    <phone>82-3410-2818</phone>
    <email>wh.chang@samsung.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won Hyuk Chang, Prof</last_name>
      <phone>82-2-3410-6068</phone>
      <email>wh.chang@samsung.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Chang WH, Bang OY, Shin YI, Lee A, Pascual-Leone A, Kim YH. BDNF polymorphism and differential rTMS effects on motor recovery of stroke patients. Brain Stimul. 2014 Jul-Aug;7(4):553-8. doi: 10.1016/j.brs.2014.03.008. Epub 2014 Mar 26.</citation>
    <PMID>24767962</PMID>
  </reference>
  <reference>
    <citation>Hwang JM, Kim YH, Yoon KJ, Uhm KE, Chang WH. Different responses to facilitatory rTMS according to BDNF genotype. Clin Neurophysiol. 2015 Jul;126(7):1348-53. doi: 10.1016/j.clinph.2014.09.028. Epub 2014 Oct 12.</citation>
    <PMID>25454277</PMID>
  </reference>
  <reference>
    <citation>Uhm KE, Kim YH, Yoon KJ, Hwang JM, Chang WH. BDNF genotype influence the efficacy of rTMS in stroke patients. Neurosci Lett. 2015 May 6;594:117-21. doi: 10.1016/j.neulet.2015.03.053. Epub 2015 Mar 26.</citation>
    <PMID>25817361</PMID>
  </reference>
  <reference>
    <citation>Chang WH, Hwang JM, Uhm KE, Pascual-Leone A, Kim YH. Corticospinal excitability in the non-dominant hand is affected by BDNF genotype. Neurol Sci. 2017 Feb;38(2):241-247. doi: 10.1007/s10072-016-2749-9. Epub 2016 Oct 25.</citation>
    <PMID>27783184</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2017</study_first_submitted>
  <study_first_submitted_qc>May 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2017</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Won Hyuk Chang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to make IPD available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

